IQVIA (IQV) to Release Quarterly Earnings on Thursday

IQVIA (NYSE:IQV) is scheduled to post its quarterly earnings results before the market opens on Thursday, October 31st. Analysts expect IQVIA to post earnings of $2.57 per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

IQVIA Stock Down 0.6 %

IQV opened at $216.34 on Wednesday. The stock’s fifty day moving average is $236.50 and its 200-day moving average is $230.16. IQVIA has a one year low of $167.42 and a one year high of $261.73. The company has a market capitalization of $39.44 billion, a PE ratio of 28.10, a P/E/G ratio of 2.09 and a beta of 1.49. The company has a debt-to-equity ratio of 1.80, a quick ratio of 0.85 and a current ratio of 0.85.

Analysts Set New Price Targets

A number of brokerages have weighed in on IQV. Evercore ISI cut their price target on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Barclays reduced their target price on shares of IQVIA from $275.00 to $260.00 and set an “overweight” rating for the company in a report on Tuesday, October 15th. Jefferies Financial Group cut IQVIA from a “buy” rating to a “hold” rating and dropped their price target for the company from $266.00 to $242.00 in a report on Wednesday, July 24th. Royal Bank of Canada started coverage on IQVIA in a research report on Wednesday, September 4th. They set an “outperform” rating and a $275.00 price objective for the company. Finally, StockNews.com upgraded IQVIA from a “hold” rating to a “buy” rating in a report on Wednesday. Four analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $267.27.

Insider Buying and Selling

In other news, insider Eric Sherbet sold 1,300 shares of the firm’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the sale, the insider now directly owns 19,536 shares of the company’s stock, valued at $4,812,302.88. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.60% of the stock is owned by corporate insiders.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.